Intuitive Surgical (NASDAQ:ISRG) Hits New 1-Year Low After Analyst Downgrade

Intuitive Surgical, Inc. (NASDAQ:ISRG) shares hit a new 52-week low on Tuesday after TD Cowen lowered their price target on the stock from $585.00 to $520.00. TD Cowen currently has a buy rating on the stock. Intuitive Surgical traded as low as $387.22 and last traded at $391.7270, with a volume of 564965 shares changing hands. The stock had previously closed at $407.12.

Several other research analysts have also weighed in on ISRG. HSBC dropped their price objective on shares of Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Citigroup reissued a “buy” rating on shares of Intuitive Surgical in a research note on Wednesday, July 8th. Zacks Research cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 30th. Mizuho set a $525.00 price target on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research note on Monday, April 13th. Finally, Jefferies Financial Group cut their price objective on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $566.27.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Iman Jeddi sold 5,625 shares of the business’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president directly owned 6,463 shares of the company’s stock, valued at $2,718,014.65. The trade was a 46.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of the business’s stock in a transaction that occurred on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the completion of the sale, the director directly owned 120 shares of the company’s stock, valued at $55,620. This represents a 49.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,169 shares of company stock worth $3,059,135 over the last ninety days. 0.60% of the stock is currently owned by insiders.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Several articles highlight Intuitive Surgical as an AI- and robotics-driven medical device leader with improving earnings estimates and strong business momentum, which could support a second-half recovery. Buy 3 AI-Led Medical Devices Laggards of 1H Set to Gather Pace in 2H
• Positive Sentiment: Commentary from 247WallSt says ISRG looks compelling ahead of earnings, with upside to fair value and analyst targets still above the current share price. Intuitive Surgical Has +35% Upside: A Compelling Buy Story Before July 16
• Positive Sentiment: Benzinga noted analysts expect higher Q2 results, with consensus calling for roughly $2.50 EPS and $2.82 billion in revenue, reinforcing hopes for a solid earnings release. Intuitive Surgical Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
• Neutral Sentiment: TD Cowen lowered its price target to $520 from $585 but kept a Buy rating, suggesting the firm still sees upside despite a more conservative valuation view. TD Cowen price target cut coverage
• Neutral Sentiment: Royal Bank of Canada also cut its target to $600 from $650 while maintaining an Outperform rating, which is a mild valuation reset rather than a bearish call. Royal Bank of Canada price target cut coverage
• Negative Sentiment: The repeated price-target reductions may pressure sentiment near term, especially as investors wait for earnings confirmation of the bullish thesis. Analyst target cut coverage

Hedge Funds Weigh In On Intuitive Surgical

Several institutional investors have recently bought and sold shares of ISRG. Draper Asset Management LLC grew its stake in shares of Intuitive Surgical by 41.9% in the fourth quarter. Draper Asset Management LLC now owns 5,029 shares of the medical equipment provider’s stock worth $2,848,000 after acquiring an additional 1,485 shares during the last quarter. Deutsche Bank AG boosted its holdings in Intuitive Surgical by 9.6% in the 4th quarter. Deutsche Bank AG now owns 1,522,191 shares of the medical equipment provider’s stock valued at $862,108,000 after purchasing an additional 132,966 shares during the period. Oppenheimer Asset Management Inc. boosted its holdings in Intuitive Surgical by 29.3% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 71,077 shares of the medical equipment provider’s stock valued at $40,255,000 after purchasing an additional 16,119 shares during the period. Procyon Advisors LLC grew its position in Intuitive Surgical by 787.8% in the 4th quarter. Procyon Advisors LLC now owns 4,794 shares of the medical equipment provider’s stock worth $2,715,000 after purchasing an additional 4,254 shares during the last quarter. Finally, Robinhood Asset Management LLC acquired a new stake in Intuitive Surgical in the 4th quarter worth $6,478,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Trading Down 4.2%

The firm’s fifty day moving average price is $421.09 and its 200-day moving average price is $472.71. The company has a market cap of $138.06 billion, a P/E ratio of 47.25, a P/E/G ratio of 3.31 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same quarter last year, the company earned $1.81 earnings per share. The firm’s revenue was up 23.0% on a year-over-year basis. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.